Literature DB >> 26429773

Drug-induced secretory diarrhea: A role for CFTR.

Changsuk Moon1, Weiqiang Zhang2,3, Nambirajan Sundaram4, Sunitha Yarlagadda1, Vadde Sudhakar Reddy1, Kavisha Arora1, Michael A Helmrath4,5, Anjaparavanda P Naren1.   

Abstract

Many medications induce diarrhea as a side effect, which can be a major obstacle to therapeutic efficacy and also a life-threatening condition. Secretory diarrhea can be caused by excessive fluid secretion in the intestine under pathological conditions. The cAMP/cGMP-regulated cystic fibrosis transmembrane conductance regulator (CFTR) is the primary chloride channel at the apical membrane of intestinal epithelial cells and plays a major role in intestinal fluid secretion and homeostasis. CFTR forms macromolecular complexes at discreet microdomains at the plasma membrane, and its chloride channel function is regulated spatiotemporally through protein-protein interactions and cAMP/cGMP-mediated signaling. Drugs that perturb CFTR-containing macromolecular complexes in the intestinal epithelium and upregulate intracellular cAMP and/or cGMP levels can hyperactivate the CFTR channel, causing excessive fluid secretion and secretory diarrhea. Inhibition of CFTR chloride-channel activity may represent a novel approach to the management of drug-induced secretory diarrhea.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CFTR chloride channel; CFTR inhibitor; CFTR-containing macromolecular complex; Drug-induced diarrhea; Intestinal fluid secretion

Mesh:

Substances:

Year:  2015        PMID: 26429773      PMCID: PMC4684461          DOI: 10.1016/j.phrs.2015.08.024

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  48 in total

1.  Antibiotic-associated diarrhea.

Authors:  Phillip Periman
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

2.  Involvement of sarcoplasmic reticulum in changing intracellular calcium due to Na+/K+-ATPase inhibition in cardiomyocytes.

Authors:  Harjot K Saini-Chohan; Ramesh K Goyal; Naranjan S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  2010-07       Impact factor: 2.273

Review 3.  Chemotherapy-induced diarrhoea.

Authors:  Rachel J Gibson; Andrea M Stringer
Journal:  Curr Opin Support Palliat Care       Date:  2009-03       Impact factor: 2.302

4.  Unusual binding interactions in PDZ domain crystal structures help explain binding mechanisms.

Authors:  Jonathan M Elkins; Carina Gileadi; Leela Shrestha; Claire Phillips; Jing Wang; João R C Muniz; Declan A Doyle
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

5.  Current concepts of laxative action: mechanisms by which laxatives increase stool water.

Authors:  M Donowitz
Journal:  J Clin Gastroenterol       Date:  1979-03       Impact factor: 3.062

Review 6.  Temporal and spatial regulation of cAMP signaling in disease: role of cyclic nucleotide phosphodiesterases.

Authors:  Carolina Otero; Juan P Peñaloza; Paula I Rodas; Ricardo Fernández-Ramires; Luis Velasquez; Juan E Jung
Journal:  Fundam Clin Pharmacol       Date:  2014-05-12       Impact factor: 2.748

Review 7.  Cyclic nucleotide phosphodiesterases: relating structure and function.

Authors:  S H Francis; I V Turko; J D Corbin
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

8.  Localizing a gate in CFTR.

Authors:  Xiaolong Gao; Tzyh-Chang Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

9.  Physiology of epithelial chloride and fluid secretion.

Authors:  Raymond A Frizzell; John W Hanrahan
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 10.  Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules.

Authors:  Frans G M Russel; Jan B Koenderink; Rosalinde Masereeuw
Journal:  Trends Pharmacol Sci       Date:  2008-03-18       Impact factor: 14.819

View more
  8 in total

1.  Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases.

Authors:  Sujin Lee; Puay-Wah Phuan; Christian M Felix; Joseph-Anthony Tan; Marc H Levin; Alan S Verkman
Journal:  J Med Chem       Date:  2017-01-31       Impact factor: 7.446

Review 2.  Apremilast: A Review in Psoriasis and Psoriatic Arthritis.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

3.  Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins.

Authors:  Onur Cil; Puay-Wah Phuan; Anne Marie Gillespie; Sujin Lee; Lukmanee Tradtrantip; Jianyi Yin; Ming Tse; Nicholas C Zachos; Ruxian Lin; Mark Donowitz; Alan S Verkman
Journal:  FASEB J       Date:  2016-11-08       Impact factor: 5.191

4.  High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators.

Authors:  Jung-Ho Son; Jie S Zhu; Puay-Wah Phuan; Onur Cil; Andrew P Teuthorn; Colton K Ku; Sujin Lee; Alan S Verkman; Mark J Kurth
Journal:  J Med Chem       Date:  2017-03-09       Impact factor: 7.446

5.  Escherichia coli Heat-Stable Enterotoxin Mediates Na+/H+ Exchanger 4 Inhibition Involving cAMP in T84 Human Intestinal Epithelial Cells.

Authors:  Ana R Beltrán; Luciene R Carraro-Lacroix; Camila N A Bezerra; Marcelo Cornejo; Katrina Norambuena; Fernando Toledo; Joaquín Araos; Fabián Pardo; Andrea Leiva; Carlos Sanhueza; Gerhard Malnic; Luis Sobrevia; Marco A Ramírez
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

6.  Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice.

Authors:  S Vamsee Raju; Lawrence Rasmussen; Peter A Sloane; Li Ping Tang; Emily Falk Libby; Steven M Rowe
Journal:  Respir Res       Date:  2017-09-18

7.  Plumbagin Prevents Secretory Diarrhea by Inhibiting CaCC and CFTR Channel Activities.

Authors:  Bo Yu; Xiaojuan Zhu; Xinyu Yang; Lingling Jin; Jia Xu; Tonghui Ma; Hong Yang
Journal:  Front Pharmacol       Date:  2019-10-09       Impact factor: 5.810

8.  Impact of NR1I2, adenosine triphosphate-binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers.

Authors:  Luping Zhou; Lulu Chen; Yaqin Wang; Jie Huang; Guoping Yang; Zhirong Tan; Yicheng Wang; Jianwei Liao; Gan Zhou; Kai Hu; Zhenyu Li; Dongsheng Ouyang
Journal:  J Ginseng Res       Date:  2018-04-28       Impact factor: 6.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.